Annual Cash & Cash Equivalents
$96.39 K
+$41.29 K+74.94%
December 31, 2023
Summary
- As of February 7, 2025, CHRO annual cash & cash equivalents is $96.39 thousand, with the most recent change of +$41.29 thousand (+74.94%) on December 31, 2023.
- CHRO annual cash & cash equivalents is now at all-time high.
Performance
CHRO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$1.25 M
-$1.15 M-47.82%
September 30, 2024
Summary
- As of February 7, 2025, CHRO quarterly cash and cash equivalents is $1.25 million, with the most recent change of -$1.15 million (-47.82%) on September 30, 2024.
- Over the past year, CHRO quarterly cash and cash equivalents has increased by +$1.16 million (+1201.89%).
- CHRO quarterly cash and cash equivalents is now -66.72% below its all-time high of $3.77 million, reached on March 31, 2024.
Performance
CHRO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CHRO Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +74.9% | +1201.9% |
| 3 y3 years | - | +624.5% |
| 5 y5 years | - | +624.5% |
CHRO Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | -66.7% | -100.0% |
| 5 y | 5-year | at high | -100.0% | -66.7% | -100.0% |
| alltime | all time | at high | -100.0% | -66.7% | -100.0% |
Chromocell Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.25 M(-47.8%) |
| Jun 2024 | - | $2.41 M(-36.2%) |
| Mar 2024 | - | $3.77 M(+3811.4%) |
| Dec 2023 | $96.39 K | $96.39 K(+322.8%) |
| Sep 2023 | - | $22.80 K(-72.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $81.90 K(+68.5%) |
| Mar 2023 | - | $48.60 K(-11.8%) |
| Dec 2022 | $55.10 K(>+9900.0%) | $55.10 K(-68.2%) |
| Sep 2022 | - | $173.20 K(>+9900.0%) |
| Dec 2021 | $0.00 | $0.00 |
FAQ
- What is Chromocell Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Chromocell Therapeutics?
- What is Chromocell Therapeutics annual cash & cash equivalents year-on-year change?
- What is Chromocell Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Chromocell Therapeutics?
- What is Chromocell Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Chromocell Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of CHRO is $96.39 K
What is the all time high annual cash & cash equivalents for Chromocell Therapeutics?
Chromocell Therapeutics all-time high annual cash & cash equivalents is $96.39 K
What is Chromocell Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, CHRO annual cash & cash equivalents has changed by +$41.29 K (+74.94%)
What is Chromocell Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CHRO is $1.25 M
What is the all time high quarterly cash and cash equivalents for Chromocell Therapeutics?
Chromocell Therapeutics all-time high quarterly cash and cash equivalents is $3.77 M
What is Chromocell Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, CHRO quarterly cash and cash equivalents has changed by +$1.16 M (+1201.89%)